Real-world use, effectiveness and safety of anti-viral treatment in chronic hepatitis C genotype 3 infection.

Markus CornbergJ PetersenA SchoberS MaussK H W BökerR LinkR GüntherY SerfertH Pfeiffer-VornkahlM P MannsC SarrazinD HüppeT BergC Niederau

Published in: Alimentary pharmacology & therapeutics (2017)

Real-world data can validate the effectiveness and safety for treatment regimens that had previously been approved with limited data, in particular for specific subgroups of patients. The present study demonstrates how rapid new scientific data, new treatment guidelines, new drug approvals and label changes are implemented into routine clinical practice today.

Keyphrases

clinical practice
big data
end stage renal disease
newly diagnosed
chronic kidney disease
machine learning
ejection fraction
prognostic factors
deep learning
patient reported outcomes
data analysis